These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | ||||
|
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | ||||
|
|
|
||||
| (State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification No.) | ||||
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||||||
|
|
|
|
||||||
|
|
x | Accelerated Filer | o | |||||||||||
| Non-Accelerated Filer | o | Smaller Reporting Company |
|
|||||||||||
| Emerging Growth Company |
|
|||||||||||||
| Class |
Outstanding at November 30, 2024
|
|||||||
| Common Stock, $.01 par value per share |
|
|||||||
| Page | ||||||||
| 13 Weeks Ended | 39 Weeks Ended | |||||||||||||||||||||||||
| November 2, 2024 | October 28, 2023 | November 2, 2024 | October 28, 2023 | |||||||||||||||||||||||
| Net sales | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||
| Other revenue |
|
|
|
|
||||||||||||||||||||||
| Total revenue |
|
|
|
|
||||||||||||||||||||||
| Cost of sales |
(
|
(
|
(
|
(
|
||||||||||||||||||||||
| Selling, general and administrative expenses |
(
|
(
|
(
|
(
|
||||||||||||||||||||||
| Gains on sale of real estate |
|
|
|
|
||||||||||||||||||||||
| Impairment, restructuring and other benefits (costs) |
|
(
|
|
(
|
||||||||||||||||||||||
| Operating income |
|
|
|
|
||||||||||||||||||||||
| Benefit plan income, net |
|
|
|
|
||||||||||||||||||||||
| Settlement charges |
|
(
|
|
(
|
||||||||||||||||||||||
| Interest expense, net |
(
|
(
|
(
|
(
|
||||||||||||||||||||||
| Losses on early retirement of debt |
(
|
|
(
|
|
||||||||||||||||||||||
| Income before income taxes |
|
|
|
|
||||||||||||||||||||||
| Federal, state and local income tax expense |
(
|
(
|
(
|
(
|
||||||||||||||||||||||
| Net income | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||
| Basic earnings per share | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||
| Diluted earnings per share | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||
| 13 Weeks Ended | 39 Weeks Ended | |||||||||||||||||||||||||
| November 2, 2024 | October 28, 2023 | November 2, 2024 | October 28, 2023 | |||||||||||||||||||||||
| Net income | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||
| Other comprehensive income: | ||||||||||||||||||||||||||
|
Actuarial gain on post employment and
postretirement benefit plans, before tax
|
|
(
|
|
(
|
||||||||||||||||||||||
| Reclassifications to net income: | ||||||||||||||||||||||||||
| Amortization of net actuarial loss and prior service credit on post employment and postretirement benefit plans included in net income, before tax |
|
|
|
|
||||||||||||||||||||||
| Settlement charges, before tax |
|
|
|
|
||||||||||||||||||||||
| Tax effect related to items of other comprehensive income |
|
|
|
(
|
||||||||||||||||||||||
| Total other comprehensive income, net of tax effect |
|
(
|
|
|
||||||||||||||||||||||
| Comprehensive income | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||
| November 2, 2024 | February 3, 2024 | October 28, 2023 | ||||||||||||||||||
| ASSETS | ||||||||||||||||||||
| Current Assets: | ||||||||||||||||||||
| Cash and cash equivalents | $ |
|
$ |
|
$ |
|
||||||||||||||
| Receivables |
|
|
|
|||||||||||||||||
| Merchandise inventories |
|
|
|
|||||||||||||||||
| Prepaid expenses and other current assets |
|
|
|
|||||||||||||||||
| Income taxes |
|
|
|
|||||||||||||||||
| Total Current Assets |
|
|
|
|||||||||||||||||
|
Property and Equipment - net of accumulated depreciation
and amortization of $
|
|
|
|
|||||||||||||||||
| Right of Use Assets |
|
|
|
|||||||||||||||||
| Goodwill |
|
|
|
|||||||||||||||||
| Other Intangible Assets – net |
|
|
|
|||||||||||||||||
| Other Assets |
|
|
|
|||||||||||||||||
| Total Assets | $ |
|
$ |
|
$ |
|
||||||||||||||
| LIABILITIES AND SHAREHOLDERS’ EQUITY | ||||||||||||||||||||
| Current Liabilities: | ||||||||||||||||||||
| Short-term debt | $ |
|
$ |
|
$ |
|
||||||||||||||
| Merchandise accounts payable |
|
|
|
|||||||||||||||||
| Accounts payable and accrued liabilities |
|
|
|
|||||||||||||||||
| Income taxes |
|
|
|
|||||||||||||||||
| Total Current Liabilities |
|
|
|
|||||||||||||||||
| Long-Term Debt |
|
|
|
|||||||||||||||||
| Long-Term Lease Liabilities |
|
|
|
|||||||||||||||||
| Deferred Income Taxes |
|
|
|
|||||||||||||||||
| Other Liabilities |
|
|
|
|||||||||||||||||
| Shareholders' Equity |
|
|
|
|||||||||||||||||
| Total Liabilities and Shareholders’ Equity | $ |
|
$ |
|
$ |
|
||||||||||||||
|
Common
Stock |
Additional
Paid-In Capital |
Accumulated
Equity |
Treasury
Stock |
Accumulated
Other Comprehensive Income (Loss) |
Total
Shareholders' Equity |
||||||||||||||||||||||||||||||
| Balance at February 3, 2024 | $ |
|
$ |
|
$ |
|
$ |
(
|
$ |
(
|
$ |
|
|||||||||||||||||||||||
| Net income |
|
|
|||||||||||||||||||||||||||||||||
|
Common stock dividends
($
|
(
|
(
|
|||||||||||||||||||||||||||||||||
| Stock-based compensation expense |
|
|
|||||||||||||||||||||||||||||||||
| Stock issued under stock plans |
(
|
|
(
|
||||||||||||||||||||||||||||||||
| Cumulative-effect adjustment (a) |
|
|
|||||||||||||||||||||||||||||||||
| Balance at May 4, 2024 | $ |
|
$ |
|
$ |
|
$ |
(
|
$ |
(
|
$ |
|
|||||||||||||||||||||||
| Net income |
|
|
|||||||||||||||||||||||||||||||||
|
Common stock dividends
($
|
|
(
|
(
|
||||||||||||||||||||||||||||||||
| Stock-based compensation expense |
|
|
|||||||||||||||||||||||||||||||||
| Stock issued under stock plans |
(
|
|
|
||||||||||||||||||||||||||||||||
| Balance at August 3, 2024 | $ |
|
$ |
|
$ |
|
$ |
(
|
$ |
(
|
$ |
|
|||||||||||||||||||||||
| Net income |
|
|
|||||||||||||||||||||||||||||||||
|
Common stock dividends
($
|
|
(
|
(
|
||||||||||||||||||||||||||||||||
| Stock-based compensation expense |
|
|
|||||||||||||||||||||||||||||||||
| Stock issued under stock plans |
(
|
|
|
||||||||||||||||||||||||||||||||
| Balance at November 2, 2024 | $ |
|
$ |
|
$ |
|
$ |
(
|
$ |
(
|
$ |
|
|||||||||||||||||||||||
|
Common
Stock |
Additional
Paid-In Capital |
Accumulated
Equity |
Treasury
Stock |
Accumulated
Other Comprehensive Income (Loss) |
Total
Shareholders' Equity |
||||||||||||||||||||||||||||||
| Balance at January 28, 2023 | $ |
|
$ |
|
$ |
|
$ |
(
|
$ |
(
|
$ |
|
|||||||||||||||||||||||
| Net income |
|
|
|||||||||||||||||||||||||||||||||
| Other comprehensive income |
|
|
|||||||||||||||||||||||||||||||||
|
Common stock dividends
($
|
(
|
(
|
|||||||||||||||||||||||||||||||||
| Stock repurchases |
(
|
(
|
|||||||||||||||||||||||||||||||||
| Stock-based compensation expense |
|
|
|||||||||||||||||||||||||||||||||
| Stock issued under stock plans |
(
|
|
(
|
||||||||||||||||||||||||||||||||
| Balance at April 29, 2023 | $ |
|
$ |
|
$ |
|
$ |
(
|
$ |
(
|
$ |
|
|||||||||||||||||||||||
| Net loss |
(
|
(
|
|||||||||||||||||||||||||||||||||
| Other comprehensive income |
|
|
|||||||||||||||||||||||||||||||||
|
Common stock dividends
($
|
|
(
|
(
|
||||||||||||||||||||||||||||||||
| Stock-based compensation expense |
|
|
|||||||||||||||||||||||||||||||||
| Stock issued under stock plans |
(
|
|
|
||||||||||||||||||||||||||||||||
| Balance at July 29, 2023 | $ |
|
$ |
|
$ |
|
$ |
(
|
$ |
(
|
$ |
|
|||||||||||||||||||||||
| Net income |
|
|
|||||||||||||||||||||||||||||||||
| Other comprehensive loss |
(
|
(
|
|||||||||||||||||||||||||||||||||
|
Common stock dividends
($
|
|
(
|
(
|
||||||||||||||||||||||||||||||||
| Stock-based compensation expense |
|
|
|||||||||||||||||||||||||||||||||
| Stock issued under stock plans |
(
|
|
|
||||||||||||||||||||||||||||||||
| Balance at October 28, 2023 | $ |
|
$ |
|
$ |
|
$ |
(
|
$ |
(
|
$ |
|
|||||||||||||||||||||||
| 39 Weeks Ended | |||||||||||
| November 2, 2024 | October 28, 2023 | ||||||||||
| Cash flows from operating activities: | |||||||||||
| Net income | $ |
|
$ |
|
|||||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||||||||
| Impairment, restructuring and other costs |
(
|
|
|||||||||
| Settlement charges |
|
|
|||||||||
| Depreciation and amortization |
|
|
|||||||||
| Stock-based compensation expense |
|
|
|||||||||
| Gains on sale of real estate |
(
|
(
|
|||||||||
| Benefit plans |
|
|
|||||||||
| Amortization of financing costs and premium on acquired debt |
|
|
|||||||||
| Deferred income taxes |
(
|
(
|
|||||||||
| Changes in assets and liabilities: | |||||||||||
| Decrease in receivables |
|
|
|||||||||
| Increase in merchandise inventories |
(
|
(
|
|||||||||
| (Increase) decrease in prepaid expenses and other current assets |
(
|
|
|||||||||
| Increase in merchandise accounts payable |
|
|
|||||||||
| Decrease in accounts payable and accrued liabilities |
(
|
(
|
|||||||||
| Decrease in current income taxes |
(
|
(
|
|||||||||
| Change in other assets and liabilities |
(
|
(
|
|||||||||
| Net cash (used) provided by operating activities |
(
|
|
|||||||||
| Cash flows from investing activities: | |||||||||||
| Purchase of property and equipment |
(
|
(
|
|||||||||
| Capitalized software |
(
|
(
|
|||||||||
| Proceeds from disposition of assets, net |
|
|
|||||||||
| Other, net |
|
(
|
|||||||||
| Net cash used by investing activities |
(
|
(
|
|||||||||
| Cash flows from financing activities: | |||||||||||
| Debt issued |
|
|
|||||||||
| Debt issuance costs |
(
|
(
|
|||||||||
| Debt repaid |
(
|
(
|
|||||||||
| Debt repurchase premium and expenses |
|
|
|||||||||
| Dividends paid |
(
|
(
|
|||||||||
| Increase in outstanding checks |
|
|
|||||||||
| Acquisition of treasury stock |
|
(
|
|||||||||
| Net cash (used) provided by financing activities |
(
|
|
|||||||||
| Net decrease in cash, cash equivalents and restricted cash |
(
|
(
|
|||||||||
| Cash, cash equivalents and restricted cash beginning of period |
|
|
|||||||||
| Cash, cash equivalents and restricted cash end of period | $ |
|
$ |
|
|||||||
| Supplemental cash flow information: | |||||||||||
| Interest paid | $ |
|
$ |
|
|||||||
| Interest received |
|
|
|||||||||
| Income taxes paid, net of refunds received |
|
|
|||||||||
| Restricted cash, end of period |
|
|
|||||||||
| 13 Weeks Ended | |||||||||||||||||||||||||||||||||||
| November 2, 2024 | October 28, 2023 | ||||||||||||||||||||||||||||||||||
| Net Income | Shares | Net Income | Shares | ||||||||||||||||||||||||||||||||
| (millions, except per share data) | |||||||||||||||||||||||||||||||||||
|
Net income and average
number of shares outstanding
|
$ |
|
|
$ |
|
|
|||||||||||||||||||||||||||||
|
Shares to be issued under
deferred compensation and other plans
|
|
|
|||||||||||||||||||||||||||||||||
| $ |
|
|
$ |
|
|
||||||||||||||||||||||||||||||
| Basic earnings per share | $ |
|
$ |
|
|||||||||||||||||||||||||||||||
| Effect of dilutive securities: | |||||||||||||||||||||||||||||||||||
|
Stock options and restricted
stock units
|
|
|
|||||||||||||||||||||||||||||||||
| $ |
|
|
$ |
|
|
||||||||||||||||||||||||||||||
| Diluted earnings per share | $ |
|
$ |
|
|||||||||||||||||||||||||||||||
| 39 Weeks Ended | |||||||||||||||||||||||||||||||||||
| November 2, 2024 | October 28, 2023 | ||||||||||||||||||||||||||||||||||
| Net Income | Shares | Net Income | Shares | ||||||||||||||||||||||||||||||||
| (millions, except per share data) | |||||||||||||||||||||||||||||||||||
|
Net income and average
number of shares outstanding
|
$ |
|
|
$ |
|
|
|||||||||||||||||||||||||||||
| Shares to be issued under deferred compensation and other plans |
|
|
|||||||||||||||||||||||||||||||||
| $ |
|
|
$ |
|
|
||||||||||||||||||||||||||||||
| Basic earnings per share | $ |
|
$ |
|
|||||||||||||||||||||||||||||||
| Effect of dilutive securities: | |||||||||||||||||||||||||||||||||||
|
Stock options and restricted
stock units
|
|
|
|||||||||||||||||||||||||||||||||
| $ |
|
|
$ |
|
|
||||||||||||||||||||||||||||||
| Diluted earnings per share | $ |
|
$ |
|
|||||||||||||||||||||||||||||||
| 13 Weeks Ended | 39 Weeks Ended | ||||||||||||||||||||||
| Revenues | November 2, 2024 | October 28, 2023 | November 2, 2024 | October 28, 2023 | |||||||||||||||||||
| (millions) | |||||||||||||||||||||||
| Women's Accessories, Shoes, Cosmetics and Fragrances | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
| Women's Apparel |
|
|
|
|
|||||||||||||||||||
| Men's and Kids' |
|
|
|
|
|||||||||||||||||||
| Home/Other (a) |
|
|
|
|
|||||||||||||||||||
| Total Net Sales |
|
|
$ |
|
$ |
|
|||||||||||||||||
| Credit card revenues, net | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
| Macy's Media Network revenue, net (b) |
|
|
|
|
|||||||||||||||||||
| Other Revenue |
|
|
|
|
|||||||||||||||||||
| Total Revenue | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
| 39 Weeks Ended | |||||||||||
| November 2, 2024 | October 28, 2023 | ||||||||||
| (millions) | |||||||||||
| Revolving credit agreement | $ |
|
$ |
|
|||||||
|
|
|
|
|||||||||
|
|
|
|
|||||||||
|
|
|
|
|||||||||
|
|
|
|
|||||||||
|
|
|
|
|||||||||
|
|
|
|
|||||||||
| $ |
|
$ |
|
||||||||
| 13 Weeks Ended | 39 Weeks Ended | ||||||||||||||||||||||
| November 2, 2024 | October 28, 2023 | November 2, 2024 | October 28, 2023 | ||||||||||||||||||||
| (millions) | |||||||||||||||||||||||
| 401(k) Qualified Defined Contribution Plan | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
| Pension Plan | |||||||||||||||||||||||
| Interest cost | $ |
|
$ |
|
|
|
|||||||||||||||||
| Expected return on assets |
(
|
(
|
(
|
(
|
|||||||||||||||||||
| Recognition of net actuarial loss |
|
|
|
|
|||||||||||||||||||
| $ |
(
|
$ |
(
|
$ |
(
|
$ |
(
|
||||||||||||||||
| Supplementary Retirement Plan | |||||||||||||||||||||||
| Interest cost | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
| Recognition of net actuarial loss |
|
|
|
|
|||||||||||||||||||
| $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||
| Total Retirement Expense | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
| Postretirement Obligations | |||||||||||||||||||||||
| Interest cost | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
| Recognition of net actuarial gain |
(
|
(
|
(
|
(
|
|||||||||||||||||||
| Amortization of prior service credit |
|
|
$ |
(
|
$ |
(
|
|||||||||||||||||
| $ |
(
|
$ |
|
$ |
(
|
$ |
(
|
||||||||||||||||
| Fair Value Measurements | |||||||||||||||||||||||
| Total | Level 1 | Level 2 | Level 3 | ||||||||||||||||||||
| (millions) | |||||||||||||||||||||||
| November 2, 2024 | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
| February 3, 2024 |
|
|
|
|
|||||||||||||||||||
| October 28, 2023 |
|
|
|
|
|||||||||||||||||||
| Notional Amount | Carrying Amount | Fair Value | |||||||||||||||
| (millions) | |||||||||||||||||
| November 2, 2024 | $ |
|
$ |
|
$ |
|
|||||||||||
| February 3, 2024 |
|
|
|
||||||||||||||
| October 28, 2023 |
|
|
|
||||||||||||||
| 52 Weeks Ended January 29, 2022 | 52 Weeks Ended January 28, 2023 | |||||||||||||||||||||||||||||||||||||
| As Reported | Adjustment | As Corrected | As Reported | Adjustment | As Corrected | |||||||||||||||||||||||||||||||||
| (millions, except per share figures) | ||||||||||||||||||||||||||||||||||||||
| Cost of sales | $ |
(
|
$ |
(
|
$ |
(
|
$ |
(
|
$ |
(
|
$ |
(
|
||||||||||||||||||||||||||
| Operating income |
|
(
|
|
|
(
|
|
||||||||||||||||||||||||||||||||
| Income before income taxes |
|
(
|
|
|
(
|
|
||||||||||||||||||||||||||||||||
| Federal, state and local income tax expense |
(
|
|
(
|
(
|
|
(
|
||||||||||||||||||||||||||||||||
| Net income |
|
(
|
|
|
(
|
|
||||||||||||||||||||||||||||||||
| Basic earnings per share |
|
(
|
|
|
(
|
|
||||||||||||||||||||||||||||||||
| Diluted earnings per share |
|
(
|
|
|
(
|
|
||||||||||||||||||||||||||||||||
| Comprehensive income |
|
(
|
|
|
(
|
|
||||||||||||||||||||||||||||||||
| 13 Weeks Ended April 29, 2023 | |||||||||||||||||||||||
| As Reported | Adjustment | As Corrected | |||||||||||||||||||||
| (millions, except per share figures) | |||||||||||||||||||||||
| Cost of sales | $ |
(
|
$ |
(
|
$ |
(
|
|||||||||||||||||
| Operating income |
|
(
|
|
||||||||||||||||||||
| Income before income taxes |
|
(
|
|
||||||||||||||||||||
| Federal, state and local income tax expense |
(
|
|
(
|
||||||||||||||||||||
| Net income |
|
(
|
|
||||||||||||||||||||
| Basic earnings per share |
|
(
|
|
||||||||||||||||||||
| Diluted earnings per share |
|
(
|
|
||||||||||||||||||||
| Comprehensive income |
|
(
|
|
||||||||||||||||||||
| 13 Weeks Ended July 29, 2023 | 26 Weeks Ended July 29, 2023 | |||||||||||||||||||||||||||||||||||||
| As Reported | Adjustment | As Corrected | As Reported | Adjustment | As Corrected | |||||||||||||||||||||||||||||||||
| (millions, except per share figures) | ||||||||||||||||||||||||||||||||||||||
| Cost of sales | $ |
(
|
$ |
|
$ |
(
|
$ |
(
|
$ |
(
|
$ |
(
|
||||||||||||||||||||||||||
| Operating income |
|
|
|
|
(
|
|
||||||||||||||||||||||||||||||||
| Income (loss) before income taxes |
(
|
|
(
|
|
(
|
|
||||||||||||||||||||||||||||||||
| Federal, state and local income tax (expense) benefit |
|
(
|
|
(
|
|
(
|
||||||||||||||||||||||||||||||||
| Net income (loss) |
(
|
|
(
|
|
(
|
|
||||||||||||||||||||||||||||||||
| Basic earnings (loss) per share |
(
|
|
(
|
|
(
|
|
||||||||||||||||||||||||||||||||
| Diluted earnings (loss) per share |
(
|
|
(
|
|
|
|
||||||||||||||||||||||||||||||||
| Comprehensive income |
|
|
|
|
(
|
|
||||||||||||||||||||||||||||||||
| 13 Weeks Ended October 28, 2023 | 39 Weeks Ended October 28, 2023 | |||||||||||||||||||||||||||||||||||||
| As Reported | Adjustment | As Corrected | As Reported | Adjustment | As Corrected | |||||||||||||||||||||||||||||||||
| (millions, except per share figures) | ||||||||||||||||||||||||||||||||||||||
| Cost of sales | $ |
(
|
$ |
(
|
$ |
(
|
$ |
(
|
$ |
(
|
$ |
(
|
||||||||||||||||||||||||||
| Operating income |
|
(
|
|
|
(
|
|
||||||||||||||||||||||||||||||||
| Income before income taxes |
|
(
|
|
|
(
|
|
||||||||||||||||||||||||||||||||
| Federal, state and local income tax expense |
(
|
|
(
|
(
|
|
(
|
||||||||||||||||||||||||||||||||
| Net income |
|
(
|
|
|
(
|
|
||||||||||||||||||||||||||||||||
| Basic earnings per share |
|
(
|
|
|
(
|
|
||||||||||||||||||||||||||||||||
| Diluted earnings per share |
|
|
|
|
(
|
|
||||||||||||||||||||||||||||||||
| Comprehensive income |
|
(
|
|
|
(
|
|
||||||||||||||||||||||||||||||||
| 13 Weeks Ended February 3, 2024 | 53 Weeks Ended February 3, 2024 | |||||||||||||||||||||||||||||||||||||
| As Reported | Adjustment | As Corrected | As Reported | Adjustment | As Corrected | |||||||||||||||||||||||||||||||||
| (in millions, except share figures) | ||||||||||||||||||||||||||||||||||||||
| Cost of sales | $ |
(
|
$ |
(
|
$ |
(
|
$ |
(
|
$ |
(
|
$ |
(
|
||||||||||||||||||||||||||
| Operating income (loss) |
(
|
(
|
(
|
|
(
|
|
||||||||||||||||||||||||||||||||
| Income (loss) before income taxes |
(
|
(
|
(
|
|
(
|
|
||||||||||||||||||||||||||||||||
| Federal, state and local income tax (expense) benefit |
|
|
|
(
|
|
|
||||||||||||||||||||||||||||||||
| Net income (loss) |
(
|
(
|
(
|
|
(
|
|
||||||||||||||||||||||||||||||||
| Basic earnings (loss) per share |
(
|
(
|
(
|
|
(
|
|
||||||||||||||||||||||||||||||||
| Diluted earnings (loss) per share |
(
|
(
|
(
|
|
(
|
|
||||||||||||||||||||||||||||||||
| Comprehensive income (loss) |
(
|
(
|
(
|
|
(
|
|
||||||||||||||||||||||||||||||||
|
October 28, 2023
|
|||||||||||||||||
| As Reported | Adjustment | As Corrected | |||||||||||||||
| (millions) | |||||||||||||||||
| Current Assets: | |||||||||||||||||
| Income taxes | $ |
|
$ |
|
$ |
|
|||||||||||
| Total Current Assets |
|
|
|
||||||||||||||
| Total Assets |
|
|
|
||||||||||||||
| Current Liabilities: | |||||||||||||||||
| Accounts payable and accrued liabilities |
|
|
|
||||||||||||||
| Total Current Liabilities |
|
|
|
||||||||||||||
| Shareholders’ Equity: | |||||||||||||||||
| Accumulated equity |
|
(
|
|
||||||||||||||
| Total Shareholders' Equity |
|
(
|
|
||||||||||||||
| Total Liabilities and Shareholders’ Equity |
|
|
|
||||||||||||||
|
February 3, 2024
|
|||||||||||||||||
| As Reported | Adjustment | As Corrected | |||||||||||||||
| (millions) | |||||||||||||||||
| Current Liabilities: | |||||||||||||||||
| Accounts payable and accrued liabilities | $ |
|
$ |
|
$ |
|
|||||||||||
| Income taxes |
|
(
|
|
||||||||||||||
| Total Current Liabilities |
|
|
|
||||||||||||||
| Shareholders’ Equity: | |||||||||||||||||
| Accumulated equity |
|
(
|
|
||||||||||||||
| Total Shareholders' Equity |
|
(
|
|
||||||||||||||
|
May 4, 2024
|
|||||||||||||||||
| As Reported | Adjustment | As Corrected | |||||||||||||||
| (millions) | |||||||||||||||||
| Current Liabilities: | |||||||||||||||||
| Accounts payable and accrued liabilities | $ |
|
$ |
|
$ |
|
|||||||||||
| Income taxes |
|
(
|
|
||||||||||||||
| Total Current Liabilities |
|
|
|
||||||||||||||
| Shareholders’ Equity: | |||||||||||||||||
| Accumulated equity |
|
(
|
|
||||||||||||||
| Total Shareholders' Equity |
|
(
|
|
||||||||||||||
|
August 3, 2024
|
|||||||||||||||||
| As Reported | Adjustment | As Corrected | |||||||||||||||
| (millions) | |||||||||||||||||
| Current Assets: | |||||||||||||||||
| Income taxes | $ |
|
$ |
|
$ |
|
|||||||||||
| Total Current Assets |
|
|
|
||||||||||||||
| Total Assets |
|
|
|
||||||||||||||
| Current Liabilities: | |||||||||||||||||
| Accounts payable and accrued liabilities |
|
|
|
||||||||||||||
| Total Current Liabilities |
|
|
|
||||||||||||||
| Shareholders’ Equity: | |||||||||||||||||
| Accumulated equity |
|
(
|
|
||||||||||||||
| Total Shareholders' Equity |
|
(
|
|
||||||||||||||
| Total Liabilities and Shareholders’ Equity |
|
|
|
||||||||||||||
| 39 Weeks Ended October 28, 2023 | |||||||||||||||||
| As Reported | Adjustment | As Corrected | |||||||||||||||
| (millions) | |||||||||||||||||
| Cash flows from operating activities: | |||||||||||||||||
| Net income | $ |
|
$ |
(
|
$ |
|
|||||||||||
| Changes in assets and liabilities: | |||||||||||||||||
|
Decrease in accounts payable and accrued liabilities
|
(
|
|
(
|
||||||||||||||
| Decrease in current income taxes |
(
|
(
|
(
|
||||||||||||||
| 52 Weeks Ended January 28, 2023 | 53 Weeks Ended February 3, 2024 | ||||||||||||||||||||||||||||||||||
| As Reported | Adjustment | As Corrected | As Reported | Adjustment | As Corrected | ||||||||||||||||||||||||||||||
| (millions) | |||||||||||||||||||||||||||||||||||
| Cash flows from operating activities: | |||||||||||||||||||||||||||||||||||
| Net income | $ |
|
$ |
(
|
$ |
|
$ |
|
$ |
(
|
$ |
|
|||||||||||||||||||||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||||||||||||||||||||||||||||||||
|
Decrease in accounts payable and accrued liabilities
|
(
|
|
(
|
(
|
|
(
|
|||||||||||||||||||||||||||||
| Decrease in current income taxes |
(
|
(
|
(
|
|
(
|
|
|||||||||||||||||||||||||||||
| Third Quarter of 2024 | Third Quarter of 2023 | ||||||||||||||||||||||||||||||||||
| Amount | % to Net Sales | % to Total Revenue | Amount | % to Net Sales | % to Total Revenue | ||||||||||||||||||||||||||||||
| (dollars in millions, except per share figures) | |||||||||||||||||||||||||||||||||||
| Net sales | $ | 4,742 | $ | 4,860 | |||||||||||||||||||||||||||||||
| Other revenue | 161 | 3.4 | % | 178 | 3.7 | % | |||||||||||||||||||||||||||||
| Total revenue | 4,903 | 5,038 | |||||||||||||||||||||||||||||||||
| Cost of sales | (2,864) | (60.4) | % | (2,905) | (59.8) | % | |||||||||||||||||||||||||||||
| Selling, general and administrative expenses | (2,064) | (42.1) | % | (2,040) | (40.5) | % | |||||||||||||||||||||||||||||
| Gains on sale of real estate | 66 | 1.3 | % | 5 | 0.1 | % | |||||||||||||||||||||||||||||
| Impairment, restructuring and other benefits (costs) | 23 | 0.5 | % | (15) | (0.3) | % | |||||||||||||||||||||||||||||
| Operating income | 64 | 1.3 | % | 83 | 1.6 | % | |||||||||||||||||||||||||||||
| Diluted earnings per share | $ | 0.10 | $ | 0.15 | |||||||||||||||||||||||||||||||
| Supplemental Financial Measures | |||||||||||||||||||||||||||||||||||
|
Gross margin (a)
|
$ | 1,878 | 39.6 | % | $ | 1,955 | 40.2 | % | |||||||||||||||||||||||||||
| Decrease in comparable sales | (2.4) | % | (7.0) | % | |||||||||||||||||||||||||||||||
| Supplemental Non-GAAP Financial Measures | |||||||||||||||||||||||||||||||||||
| Decrease in comparable sales on an owned-plus-licensed-plus-marketplace basis | (1.3) | % | (6.3) | % | |||||||||||||||||||||||||||||||
| Adjusted diluted earnings per share | $ | 0.04 | $ | 0.21 | |||||||||||||||||||||||||||||||
| EBITDA | $ | 296 | $ | 309 | |||||||||||||||||||||||||||||||
| Adjusted EBITDA | $ | 273 | $ | 331 | |||||||||||||||||||||||||||||||
| Third Quarter of 2024 | Third Quarter of 2023 | |||||||||||||
| Net sales | $ | 4,742 | $ | 4,860 | ||||||||||
| Decrease in comparable sales | (2.4) | % | (7.0) | % | ||||||||||
| Decrease in comparable sales on an owned-plus-licensed-plus-marketplace basis | (1.3) | % | (6.3) | % | ||||||||||
| Third Quarter of 2024 | Third Quarter of 2023 | |||||||||||||||||||||||||
| $ | % to Net Sales | $ | % to Net Sales | |||||||||||||||||||||||
| Credit card revenues, net | $ | 120 | 2.5 | % | $ | 142 | 2.9 | % | ||||||||||||||||||
| Macy's Media Network, net | 41 | 0.9 | % | 36 | 0.7 | % | ||||||||||||||||||||
| Other revenue | $ | 161 | 3.4 | % | $ | 178 | 3.7 | % | ||||||||||||||||||
| Third Quarter of 2024 | Third Quarter of 2023 | |||||||||||||
| Cost of sales | $ | (2,864) | (2,905) | |||||||||||
| As a percent to net sales | 60.4 | % | 59.8 | % | ||||||||||
| Gross margin | $ | 1,878 | $ | 1,955 | ||||||||||
| As a percent to net sales | 39.6 | % | 40.2 | % | ||||||||||
| Third Quarter of 2024 | Third Quarter of 2023 | |||||||||||||
| SG&A expenses | $ | (2,064) | $ | (2,040) | ||||||||||
| As a percent to total revenue | 42.1 | % | 40.5 | % | ||||||||||
| Third Quarter of 2024 | Third Quarter of 2023 | |||||||||||||
| Gains on sale of real estate | $ | 66 | $ | 5 | ||||||||||
| Third Quarter of 2024 | Third Quarter of 2023 | |||||||||||||
| Settlement charges | $ | — | $ | (7) | ||||||||||
| Third Quarter of 2024 | Third Quarter of 2023 | |||||||||||||
| Net interest expense | $ | (32) | $ | (35) | ||||||||||
| Third Quarter of 2024 | Third Quarter of 2023 | |||||||||||||
| Effective tax rate | 20.0 | % | 4.7 | % | ||||||||||
| Federal income statutory rate | 21 | % | 21 | % | ||||||||||
| 39 Weeks Ended November 2, 2024 | 39 Weeks Ended October 28, 2023 | ||||||||||||||||||||||||||||||||||
| Amount | % to Net Sales | % to Total Revenue | Amount | % to Net Sales | % to Total Revenue | ||||||||||||||||||||||||||||||
| (dollars in millions, except per share figures) | |||||||||||||||||||||||||||||||||||
| Net sales | $ | 14,525 | $ | 14,972 | |||||||||||||||||||||||||||||||
| Other revenue | 474 | 3.3 | % | 519 | 3.5 | % | |||||||||||||||||||||||||||||
| Total revenue | 14,999 | 15,491 | |||||||||||||||||||||||||||||||||
| Cost of sales | (8,749) | (60.2) | % | (9,070) | (60.6) | % | |||||||||||||||||||||||||||||
| Selling, general and administrative expenses | (5,948) | (39.7) | % | (5,970) | (38.5) | % | |||||||||||||||||||||||||||||
| Gains on sale of real estate | 103 | 0.7 | % | 20 | 0.1 | % | |||||||||||||||||||||||||||||
| Impairment, restructuring and other benefits (costs) | 5 | — | % | (21) | (0.1) | % | |||||||||||||||||||||||||||||
| Operating income | $ | 410 | 2.7 | % | $ | 450 | 2.9 | % | |||||||||||||||||||||||||||
| Diluted earnings per share | $ | 0.85 | $ | 0.62 | |||||||||||||||||||||||||||||||
| Supplemental Financial Measures | |||||||||||||||||||||||||||||||||||
| Gross margin (a) | $ | 5,776 | 39.8 | % | $ | 5,902 | 39.4 | % | |||||||||||||||||||||||||||
| Decrease in comparable sales | (2.5) | % | (7.7) | % | |||||||||||||||||||||||||||||||
| Supplemental Non-GAAP Financial Measures | |||||||||||||||||||||||||||||||||||
| Decrease in comparable sales on an owned-plus-licensed-plus-marketplace basis | (1.6) | % | (6.9) | % | |||||||||||||||||||||||||||||||
| Adjusted diluted earnings per share | $ | 0.84 | $ | 1.02 | |||||||||||||||||||||||||||||||
| EBITDA | $ | 1,079 | $ | 996 | |||||||||||||||||||||||||||||||
| Adjusted EBITDA | $ | 1,074 | $ | 1,146 | |||||||||||||||||||||||||||||||
| 2024 | 2023 | |||||||||||||
| Net sales | $ | 14,525 | $ | 14,972 | ||||||||||
| Decrease in comparable sales | (2.5) | % | (7.7) | % | ||||||||||
| Decrease in comparable sales on an owned-plus-licensed-plus-marketplace basis | (1.6) | % | (6.9) | % | ||||||||||
| 2024 | 2023 | |||||||||||||||||||||||||
| $ | % to Net Sales | $ | % to Net Sales | |||||||||||||||||||||||
| Credit card revenues, net | $ | 362 | 2.5 | % | $ | 424 | 2.8 | % | ||||||||||||||||||
| Macy's Media Network, net | 112 | 0.8 | % | 95 | 0.6 | % | ||||||||||||||||||||
| Other revenue | $ | 474 | 3.3 | % | $ | 519 | 3.5 | % | ||||||||||||||||||
| 2024 | 2023 | |||||||||||||
| Cost of sales | $ | (8,749) | $ | (9,070) | ||||||||||
| As a percent to net sales | 60.2 | % | 60.6 | % | ||||||||||
| Gross margin | $ | 5,776 | $ | 5,902 | ||||||||||
| As a percent to net sales | 39.8 | % | 39.4 | % | ||||||||||
| 2024 | 2023 | |||||||||||||
| SG&A expenses | $ | (5,948) | $ | (5,970) | ||||||||||
| As a percent to total revenue | 39.7 | % | 38.5 | % | ||||||||||
| 2024 | 2023 | |||||||||||||
| Gains on sale of real estate | $ | 103 | $ | 20 | ||||||||||
| 2024 | 2023 | |||||||||||||
| Settlement charges | $ | — | $ | (129) | ||||||||||
| 2024 | 2023 | |||||||||||||
| Net interest expense | $ | (94) | $ | (108) | ||||||||||
| 2024 | 2023 | |||||||||||||
| Effective tax rate | 26.6 | % | 22.4 | % | ||||||||||
| Federal income statutory rate | 21 | % | 21 | % | ||||||||||
| 2024 | 2023 | |||||||||||||
| Net cash (used) provided by operating activities | $ | (30) | $ | 158 | ||||||||||
| Net cash used by investing activities | (455) | (716) | ||||||||||||
| Net cash (used) provided by financing activities | (234) | 60 | ||||||||||||
| November 2, 2024 | February 3, 2024 | ||||||||||
| (in millions) | |||||||||||
| ASSETS | |||||||||||
| Current Assets | $ | 1,087 | $ | 1,028 | |||||||
| Noncurrent Assets | 6,205 | 6,145 | |||||||||
| LIABILITIES | |||||||||||
| Current Liabilities | $ | 1,754 | $ | 1,800 | |||||||
| Noncurrent Liabilities (a) | 11,222 | 10,654 | |||||||||
|
13 Weeks Ended
November 2, 2024 |
39 Weeks Ended
November 2, 2024 |
||||||||||
| (in millions) | |||||||||||
| Net sales | $ | 167 | $ | 582 | |||||||
| Consignment commission income (a) | 759 | 2,309 | |||||||||
| Other revenue | 42 | 112 | |||||||||
| Cost of sales | (80) | (278) | |||||||||
| Operating loss | (379) | (1,034) | |||||||||
| Loss before income taxes (b) | (318) | (844) | |||||||||
| Net loss | (193) | (526) | |||||||||
|
13 Weeks Ended November 2, 2024 vs.
13 Weeks Ended October 28, 2023
|
|||||||||||||||||
| Macy's, Inc. | Macy's | ||||||||||||||||
| Decrease in comparable sales on an owned basis (Note 1) | (2.4 | %) | (3.0 | %) | |||||||||||||
| Impact of departments licensed to third parties and marketplace sales (Note 2) | 1.1 | % | 0.8 | % | |||||||||||||
| Decrease in comparable sales on an owned-plus-licensed-plus-marketplace basis | (1.3 | %) | (2.2 | %) | |||||||||||||
|
13 Weeks Ended November 2, 2024 vs.
13 Weeks Ended October 28, 2023
|
|||||||||||||||||||||||
| Macy's, Inc. go-forward business | Macy's go-forward business | Bloomingdale's (a) | Bluemercury | ||||||||||||||||||||
| Increase (decrease) in comparable sales on an owned basis (Note 1) | (2.0) | % | (2.6) | % | 1.0 | % | 3.3 | % | |||||||||||||||
| Impact of departments licensed to third parties and marketplace sales (Note 2) | 1.1 | % | 0.8 | % | 2.2 | % | — | % | |||||||||||||||
| Increase (decrease) in comparable sales on an owned-plus-licensed-plus-marketplace basis | (0.9 | %) | (1.8 | %) | 3.2 | % | 3.3 | % | |||||||||||||||
|
13 Weeks Ended November 2, 2024 vs.
13 Weeks Ended October 28, 2023
|
|||||||||||||||||||||||
| Macy's First 50 locations | |||||||||||||||||||||||
| Increase (decrease) in comparable sales on an owned basis (Note 1) | 1.9 | % | |||||||||||||||||||||
| Impact of departments licensed to third parties (Note 2) | — | % | |||||||||||||||||||||
| Increase (decrease) in comparable sales on an owned-plus-licensed basis | 1.9 | % | |||||||||||||||||||||
|
39 Weeks Ended November 2, 2024 vs.
39 Weeks Ended October 28, 2023
|
|||||||||||
| Macy's, Inc. | |||||||||||
| Decrease in comparable sales on an owned basis (Note 1) | (2.5 | %) | |||||||||
| Impact of departments licensed to third parties and marketplace sales (Note 2) | 0.9 | % | |||||||||
| Decrease in comparable sales on an owned-plus-licensed-plus-marketplace basis | (1.6 | %) | |||||||||
|
13 Weeks Ended October 28, 2023 vs.
13 Weeks Ended October 29, 2022
|
39 Weeks Ended October 28, 2023 vs.
39 Weeks Ended October 29, 2022
|
||||||||||
| Macy's, Inc. | |||||||||||
| Decrease in comparable sales on an owned basis (Note 1) | (7.0 | %) | (7.7 | %) | |||||||
| Impact of departments licensed to third parties and marketplace sales (Note 2) | 0.7 | % | 0.8 | % | |||||||
| Decrease in comparable sales on an owned-plus-licensed-plus-marketplace basis | (6.3 | %) | (6.9 | %) | |||||||
|
13 Weeks Ended
November 2, 2024 |
13 Weeks Ended October 28, 2023
1
|
39 Weeks Ended November 2, 2024
|
39 Weeks Ended October 28, 2023
1
|
||||||||||||||||||||
| (millions) | |||||||||||||||||||||||
| Net income | $ | 28 | $ | 41 | $ | 240 | $ | 173 | |||||||||||||||
| Interest expense - net | 32 | 35 | 94 | 108 | |||||||||||||||||||
| Losses on early retirement of debt | 1 | — | 1 | — | |||||||||||||||||||
| Federal, state and local income tax expense | 7 | 2 | 87 | 50 | |||||||||||||||||||
| Depreciation and amortization | 228 | 231 | 657 | 665 | |||||||||||||||||||
| EBITDA | $ | 296 | $ | 309 | $ | 1,079 | $ | 996 | |||||||||||||||
| Impairment, restructuring and other costs (benefits) | (23) | 15 | (5) | 21 | |||||||||||||||||||
| Settlement charges | — | 7 | — | 129 | |||||||||||||||||||
| Adjusted EBITDA | $ | 273 | $ | 331 | $ | 1,074 | $ | 1,146 | |||||||||||||||
| 13 Weeks Ended November 2, 2024 |
13 Weeks Ended October 28, 2023
1
|
||||||||||||||||||||||
| Net Income |
Diluted
Earnings Per Share |
Net Income |
Diluted
Earnings Per Share |
||||||||||||||||||||
| (millions, except per share figures) | |||||||||||||||||||||||
| As reported | $ | 28 | $ | 0.10 | $ | 41 | $ | 0.15 | |||||||||||||||
| Impairment, restructuring and other costs (benefits) | (23) | (0.08) | 15 | 0.05 | |||||||||||||||||||
| Settlement charges | — | — | 7 | 0.03 | |||||||||||||||||||
| Losses on early retirement of debt | 1 | — | — | — | |||||||||||||||||||
| Income tax impact of certain items noted above | 5 | 0.02 | (6) | (0.02) | |||||||||||||||||||
| As adjusted to exclude certain items above | $ | 11 | $ | 0.04 | $ | 57 | $ | 0.21 | |||||||||||||||
| 39 Weeks Ended November 2, 2024 |
39 Weeks Ended October 28, 2023
1
|
||||||||||||||||||||||
| Net Income |
Diluted
Earnings Per Share |
Net Income |
Diluted
Earnings Per Share |
||||||||||||||||||||
| (millions, except per share figures) | |||||||||||||||||||||||
| As reported | $ | 240 | $ | 0.85 | $ | 173 | $ | 0.62 | |||||||||||||||
| Impairment, restructuring and other costs (benefits) | (5) | (0.01) | 21 | 0.07 | |||||||||||||||||||
| Settlement charges | — | — | 129 | 0.46 | |||||||||||||||||||
| Losses on early retirement of debt | 1 | — | — | — | |||||||||||||||||||
| Income tax impact of certain items noted above | 1 | — | (38) | (0.13) | |||||||||||||||||||
| As adjusted to exclude certain items above | $ | 237 | $ | 0.84 | $ | 285 | $ | 1.02 | |||||||||||||||
|
13 Weeks Ended October 28, 2023
|
39 Weeks Ended October 28, 2023
|
||||||||||||||||||||||||||||||||||
| As Reported | Adjustment | As Corrected | As Reported | Adjustment | As Corrected | ||||||||||||||||||||||||||||||
| (millions) | |||||||||||||||||||||||||||||||||||
| Net income | $ | 43 | $ | (2) | $ | 41 | $ | 175 | $ | (2) | $ | 173 | |||||||||||||||||||||||
| Interest expense - net | 35 | — | 35 | 108 | — | 108 | |||||||||||||||||||||||||||||
| Losses on early retirement of debt | — | — | — | — | — | — | |||||||||||||||||||||||||||||
| Federal, state and local income tax expense | 3 | (1) | 2 | 51 | (1) | 50 | |||||||||||||||||||||||||||||
| Depreciation and amortization | 231 | — | 231 | 665 | — | 665 | |||||||||||||||||||||||||||||
| EBITDA | $ | 312 | $ | (3) | $ | 309 | $ | 999 | $ | (3) | $ | 996 | |||||||||||||||||||||||
| Impairment, restructuring and other costs (benefits) | 15 | — | 15 | 21 | — | 21 | |||||||||||||||||||||||||||||
| Settlement charges | 7 | — | 7 | 129 | — | 129 | |||||||||||||||||||||||||||||
| Adjusted EBITDA | $ | 334 | $ | (3) | $ | 331 | $ | 1,149 | $ | (3) | $ | 1,146 | |||||||||||||||||||||||
|
13 Weeks Ended October 28, 2023
|
|||||||||||||||||||||||||||||||||||
| As Reported | Adjustment | As Corrected | |||||||||||||||||||||||||||||||||
| Net Income |
Diluted
Earnings Per Share |
Net Income |
Diluted
Earnings Per Share |
Net Income |
Diluted
Earnings Per Share |
||||||||||||||||||||||||||||||
| (millions, except per share figures) | |||||||||||||||||||||||||||||||||||
| As reported | $ | 43 | $ | 0.15 | $ | (2) | $ | — | $ | 41 | $ | 0.15 | |||||||||||||||||||||||
| Impairment, restructuring and other costs (benefits) | 15 | 0.05 | — | — | 15 | 0.05 | |||||||||||||||||||||||||||||
| Settlement charges | 7 | 0.03 | — | — | 7 | 0.03 | |||||||||||||||||||||||||||||
| Income tax impact of certain items noted above | (6) | (0.02) | — | — | (6) | (0.02) | |||||||||||||||||||||||||||||
| As adjusted to exclude certain items above | $ | 59 | $ | 0.21 | $ | (2) | $ | — | $ | 57 | $ | 0.21 | |||||||||||||||||||||||
|
39 Weeks Ended October 28, 2023
|
|||||||||||||||||||||||||||||||||||
| As Reported | Adjustment | As Corrected | |||||||||||||||||||||||||||||||||
| Net Income |
Diluted
Earnings Per Share |
Net Income |
Diluted
Earnings Per Share |
Net Income |
Diluted
Earnings Per Share |
||||||||||||||||||||||||||||||
| (millions, except per share figures) | |||||||||||||||||||||||||||||||||||
| As reported | $ | 175 | $ | 0.63 | $ | (2) | $ | (0.01) | $ | 173 | $ | 0.62 | |||||||||||||||||||||||
| Impairment, restructuring and other costs (benefits) | 21 | 0.07 | — | — | 21 | 0.07 | |||||||||||||||||||||||||||||
| Settlement charges | 129 | 0.46 | — | — | 129 | 0.46 | |||||||||||||||||||||||||||||
| Income tax impact of certain items noted above | (38) | (0.13) | — | — | (38) | (0.13) | |||||||||||||||||||||||||||||
| As adjusted to exclude certain items above | $ | 287 | $ | 1.03 | $ | (2) | $ | (0.01) | $ | 285 | $ | 1.02 | |||||||||||||||||||||||
| 22 | ||||||||
| 31.1 | ||||||||
| 31.2 | ||||||||
| 32.1 | ||||||||
| 32.2 | ||||||||
| 101 |
The following financial statements from Macy's, Inc.'s Quarterly Report on Form 10-Q for the quarter ended November 2, 2024, filed on December 12, 2024, formatted in iXBRL (Inline eXtensible Business Reporting Language): (i) Consolidated Statements of Income, (ii) Consolidated Statements of Comprehensive Income, (iii) Consolidated Balance Sheets, (iv) Consolidated Statements of Changes in Shareholders' Equity, (v) Consolidated Statements of Cash Flows, and (vi) the Notes to Consolidated Financial Statements.
|
|||||||
| 104 | Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101) | |||||||
| MACY'S, INC. | ||||||||
| By: | /s/ TRACY M. PRESTON | |||||||
|
Tracy M. Preston
Chief Legal Officer and Corporate Secretary |
||||||||
| By: | /s/ PAUL GRISCOM | |||||||
|
Paul Griscom
Senior Vice President and Controller
|
||||||||
|
Date: December 12, 2024
|
||||||||
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
Suppliers
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|